Circulation Research, Vol 65, 531-537, Copyright © 1989 by American Heart Association

ARTICLES

Metabolism of adenine nucleotides in human blood

SB Coade and JD Pearson
Section of Vascular Biology, MRC Clinical Research Centre, Harrow, Middlesex, England.

Biologically active concentrations of potently vasoactive and platelet- active adenine nucleotides are generated in plasma by a variety of pathophysiological mechanisms. Although there is evidence that ATP and ADP are inactivated by endothelial ectonucleotidases, there has been little attempt to study the metabolic routes of their catabolism in blood or to assess the contribution of this process to their clearance in vivo. Therefore, we have studied the rates and patterns of catabolism of ATP, ADP, and AMP in whole blood, plasma, and isolated blood cells. Rates of degradation of each nucleotide in cell-free plasma ranged from 0.07-0.32 nmol/min/ml with 1 microM substrates to 1.1-3.6 nmol/min/ml with 100 microM substrates. The pattern of catabolism indicated that sequential dephosphorylation from ATP----ADP-- --AMP----adenosine occurs. In whole blood, the pattern was similar although ATP and ADP (but not AMP) breakdown was more rapid. This was due to leukocyte ectonucleotidase activity. The use of selective inhibitors demonstrated that catabolism was not due to nonspecific phosphatase activity and that plasma 5'-nucleotidase is distinct from ATPase or ADPase. In leukocytes, ATPase and ADPase activities were distinguishable, and each contributed substantially to the rates of catabolism in whole blood. Leukocyte 5'-nucleotidase did not measurably contribute to AMP dephosphorylation in blood. By comparison, ecto- ATPase and ecto-ADPase activities on cultured human umbilical vein endothelial cells were similar to those on leukocytes while endothelial 5'-nucleotidase per 10(6) cells was equivalent to the soluble activity in 1 ml of blood or plasma.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. S. Song, T.-J. Lee, K. Kim, K. C. Chung, and J.-H. Yoon cAMP-responding Element-binding Protein and c-Ets1 Interact in the Regulation of ATP-dependent MUC5AC Gene Expression J. Biol. Chem., October 3, 2008; 283(40): 26869 - 26878. [Abstract] [Full Text] [PDF]

				K. R. Vaughan, L. Stokes, L. R. Prince, H. M. Marriott, S. Meis, M. U. Kassack, C. D. Bingle, I. Sabroe, A. Surprenant, and M. K. B. Whyte Inhibition of Neutrophil Apoptosis by ATP Is Mediated by the P2Y11 Receptor J. Immunol., December 15, 2007; 179(12): 8544 - 8553. [Abstract] [Full Text] [PDF]

				G. G. Yegutkin, S. S. Samburski, S. P. Mortensen, S. Jalkanen, and J. Gonzalez-Alonso Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans J. Physiol., March 1, 2007; 579(2): 553 - 564. [Abstract] [Full Text] [PDF]

				S. Heptinstall, J. R. Glenn, A. Johnson, B. Myers, A. E. White, and L. Zhao Leukocytosis, Vascular Disease, and Adenine Nucleotide Metabolism Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): e22 - e23. [Full Text] [PDF]

				I. A. Kolosova, T. Mirzapoiazova, D. Adyshev, P. Usatyuk, L. H. Romer, J. R. Jacobson, V. Natarajan, D. B. Pearse, J. G.N. Garcia, and A. D. Verin Signaling Pathways Involved in Adenosine Triphosphate-Induced Endothelial Cell Barrier Enhancement Circ. Res., July 22, 2005; 97(2): 115 - 124. [Abstract] [Full Text] [PDF]

				V. Randriamboavonjy, J. Schrader, R. Busse, and I. Fleming Insulin Induces the Release of Vasodilator Compounds From Platelets by a Nitric Oxide-G Kinase-VAMP-3-dependent Pathway J. Exp. Med., February 2, 2004; 199(3): 347 - 356. [Abstract] [Full Text] [PDF]

				N. P. Stafford, A. E. Pink, A. E. White, J. R. Glenn, and S. Heptinstall Mechanisms Involved in Adenosine Triphosphate-Induced Platelet Aggregation in Whole Blood Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1928 - 1933. [Abstract] [Full Text] [PDF]

				C. Oury, M. J. E. Kuijpers, E. Toth-Zsamboki, A. Bonnefoy, S. Danloy, I. Vreys, M. A. H. Feijge, R. De Vos, J. Vermylen, J. W. M. Heemskerk, et al. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype Blood, May 15, 2003; 101(10): 3969 - 3976. [Abstract] [Full Text] [PDF]

				M. Hou, T. K. Harden, C. M. Kuhn, B. Baldetorp, E. Lazarowski, W. Pendergast, S. Moller, L. Edvinsson, and D. Erlinge UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y6 receptors Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H784 - H792. [Abstract] [Full Text] [PDF]

				A. HOEBERTZ, S. MEGHJI, G. BURNSTOCK, and T. R. ARNETT Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y1 receptor on bone cells FASEB J, May 1, 2001; 15(7): 1139 - 1148. [Abstract] [Full Text] [PDF]

				A. I. Kuzmin, V. L. Lakomkin, V. I. Kapelko, and G. Vassort Interstitial ATP level and degradation in control and postmyocardial infarcted rats Am J Physiol Cell Physiol, September 1, 1998; 275(3): C766 - C771. [Abstract] [Full Text] [PDF]

				K. Schror Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel Vascular Medicine, August 1, 1998; 3(3): 247 - 251. [Abstract] [PDF]

				E. E. Clifford, K. Parker, B. D. Humphreys, S. B. Kertesy, and G. R. Dubyak The P2X1 Receptor, an Adenosine Triphosphate-Gated Cation Channel, Is Expressed in Human Platelets but not in Human Blood Leukocytes Blood, May 1, 1998; 91(9): 3172 - 3181. [Abstract] [Full Text] [PDF]

				S. Patil, J. E. Kaplan, and F. L. Minnear Protein, not adenosine or adenine nucleotides, mediates platelet decrease in endothelial permeability Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2304 - H2311. [Abstract] [Full Text] [PDF]

				H. Ninomiya, H. Otani, K. Lu, T. Uchiyama, M. Kido, and H. Imamura Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1933 - H1943. [Abstract] [Full Text] [PDF]